featuring performances by:
and a brief presentation by Dr. Steven Zeitels
Steven M. Zeitels, MD, FACS, is the Eugene B. Casey Professor of Laryngeal Surgery at Harvard Medical School (HMS), and the Director of the Center for Laryngeal Surgery and Voice Rehabilitation the Massachusetts General Hospital (MGH). Dr. Zeitels serves as Laryngologist to various voice departments in Boston, as well as to the American Repertory Theatre at Harvard University, the Boston Lyric Opera, and the Boston University Huntington Theatre.
Dr. Zeitels has been a productive surgical innovator designing more than 20 new laryngeal and pharyngeal procedures as well as three laryngoscope patents. His clients have included Adele, Julie Andrews, Steven Tyler, Cher, Joe Buck, Dick Vitale, Lionel Richie, Roger Daltrey, Paul Stanley, Christina Perri, Denyce Graves, Frederica von Stade, Carol Vaness, Livingston Taylor, Anna Vissi, Sam Wyche, Jim O'Brien, Charlie Moore and David Brudnoy. His patients have been strong supporters of research and education and formed the nonprofit Voice Health Institute (VHI), formerly known as the Institute for Laryngology and Voice Restoration (ILVR) to help others with laryngeal and voice disorders. Julie Andrews serves as the Honorary chairwoman of the VHI Advisory Board. Along with Julie Andrews, Steven Tyler, Denyce Graves, Joe Buck and Roger Daltrey have been active collaborators with Zeitels to advance the cause of restoring lost voices. In Roger Daltrey's case, Zeitels removed precancerous dysplasia from his vocal fold just one month prior to his 2010 Super Bowl performance.
Zeitels conceived and directs the Voice Restoration Research Program, which is a collaborative effort of investigators at Harvard and MGH, as well as Robert Langer at MIT. They have spent over a decade developing a biomaterial that would restore the largest majority of human voice loss and the research group received the 2010 Broyles Maloney Award of the American Bronchoesophagological Association for their effort. They hope to initiate human trials to test the new vocal biogel in early 2013. [wiki]